ArticleJournal of inflammation research2025
Network Analysis of Multidimensional Symptoms and Inflammatory Biomarkers in Chinese Patients with Glioma.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Identifying Core Symptoms in Breast Cancer Patients with Different Chemotherapy Phases Using Network Analysis: A Prospective Multicenter Longitudinal Study.Patient preference and adherence · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with glioma experience multidimensional symptoms that reduce their functional status, quality of life, and survival, and these symptoms may be associated with inflammation. This study applied network analysis to examine and visualize the relationship between multidimensional symptom experiences and inflammatory biomarkers and assess the symptom networks of multidimensional symptom experiences over time in patients with glioma. Methods: Participants diagnosed with glioma were recruited and completed the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) at three different time points: 2 days after admission (T1), 7 days after surgery (T2), and 1 month after surgery (T3). On the same day as the T1 questionnaire collection, plasma levels of interleukin-1β (IL-1β), IL-6, IL-10, tumor necrosis factor-α (TNF-α), and c-reactive protein (CRP) were measured. Network analysis was employed to explore the relationships among multidimensional symptom experiences and inflammatory biomarkers of patients. Results: Of the total 334 participants (mean age 54.38 ± 13.16 years), 67.1% had high-grade tumors. In the symptom-cytokine network model, there were positive correlations between "sad and IL-6", "fatigue and IL-10", and "sleepy and IL-1β". Within the symptom network models, "difficulty remembering", "sad", and "change in bowel pattern" emerged as the most central symptoms across the three assessments, respectively. Conclusion: Network analysis provides a novel method for investigating the relationships between multidimensional symptom experiences and inflammatory biomarkers. Additionally, it allows for identifying different core symptoms at various stages of treatment. Clinicians should effectively address and manage symptoms by focusing on special core symptoms and their interconnections within the network.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.